Altshuler Shaham’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,500
| Closed | -$218K | – | 380 |
|
|
2025
Q2 | $218K | Buy |
+2,500
| New | +$196K | 0.01% | 148 |
|
|
2023
Q4 | – | Sell |
-2,664
| Closed | -$249K | – | 281 |
|
|
2023
Q3 | $249K | Sell |
2,664
-1,336
| -33% | -$151K | 0.01% | 90 |
|
|
2023
Q2 | $514K | Hold |
4,000
| – | – | 0.01% | 71 |
|
|
2023
Q1 | $465K | Sell |
4,000
-225
| -5% | -$25.2K | 0.01% | 76 |
|
|
2022
Q4 | $478K | Sell |
4,225
-1,275
| -23% | -$140K | 0.02% | 66 |
|
|
2022
Q3 | $385K | Buy |
+5,500
| New | +$466K | 0.01% | 111 |
|
|
2022
Q2 | – | Sell |
-4,000
| Closed | -$512K | – | 481 |
|
|
2022
Q1 | $512K | Buy |
4,000
+1,772
| +80% | +$194K | ﹤0.01% | 184 |
|
|
2021
Q4 | $303K | Buy |
2,228
+460
| +26% | +$66.1K | 0.01% | 220 |
|
|
2021
Q3 | $242K | Buy |
1,768
+432
| +32% | +$54.5K | ﹤0.01% | 237 |
|
|
2021
Q2 | $143K | Hold |
1,336
| – | – | ﹤0.01% | 283 |
|
|
2021
Q1 | $120K | Hold |
1,336
| – | – | ﹤0.01% | 204 |
|
|
2020
Q4 | $123K | Sell |
1,336
-784
| -37% | -$70K | ﹤0.01% | 181 |
|
|
2020
Q3 | $219K | Buy |
2,120
+136
| +7% | +$14.2K | 0.01% | 137 |
|
|
2020
Q2 | $201K | Buy |
1,984
+120
| +6% | +$10.7K | 0.01% | 124 |
|
|
2020
Q1 | $126K | Buy |
1,864
+1,620
| +664% | +$101K | 0.01% | 153 |
|
|
2019
Q4 | $13K | Buy |
+244
| New | +$11.6K | ﹤0.01% | 312 |
|
|
2019
Q2 | – | Sell |
-220
| Closed | -$7K | – | 372 |
|
|
2019
Q1 | $7K | Sell |
220
-32
| -13% | -$1.13K | ﹤0.01% | 279 |
|
|
2018
Q4 | $8K | Buy |
252
+56
| +29% | +$1.78K | ﹤0.01% | 191 |
|
|
2018
Q3 | $7K | Buy |
+196
| New | +$6.08K | ﹤0.01% | 201 |
|
Other funds holding DXCM
N
